EGFR and neoplasm: Moreover, tumor-associated macrophages (TAMs) in EGFR-mutated NSCLC exhibit an immunosuppressive M2 phenotype, secreting factors like IL-10 and VEGF, which promote tumor progression and immune evasion [6,72].